Pregnancy and Childbirth
Conditions
Interventions
Placebo
Sponsors
Preeclampsia Research Laboratories PEARLS Heart Research Institute
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1 All urban health centres providing maternal health services in Blantyre 2 All Pregnant women screened and identified to be at risk of preeclampsia/ eclampsia such as those with: Hypertensive disease during previous pregnancy Chronic kidney disease Type 1&2 diabetes Chronic hypertension Auto immune disease such as systematic lupus erythematosus or antiphospholipid syndrome previous history of preeclampsia/eclampsia, previous an explained abruption advanced maternal/extreme of age, teenagers 3. Those with family history of eclampsia/preeclampsia, twin pregnancy, chronic hypertension, diabetes ) 4. They should be between 11 to 16 weeks gestation
Exclusion criteria
Exclusion criteria: 1. All women with increased risk of bleeding due to coagulation disorders or placenta previa 2. Women who are allergic to aspirin or calcium 3. Women who are planning to deliver at another health facility 4. All women who did not consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| preeclampsia and or eclampsia | — |
Secondary
| Measure | Time frame |
|---|---|
| Maternal mortality, placenta abruptio, admission to ICU, stroke, post partum haemorrhage, timing of delivery, gestational age at delivery, HELLP syndrome, near miss event, birth weight, admission in nursery ICU, intra uterine death, fresh still birth, small for gestational age or neonatal respiratory support. | — |
Countries
Malawi
Contacts
Public ContactEric Umar
COMREC chair
Outcome results
None listed